The high prevalence of sarcopenia in patients with ovarian and endometrial cancers underscores the importance of early ...
Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new UVA Cancer Center research ...
Researchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at ...
University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer by discovering how gut bacteria interfere with the treatment.
University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer ...
UVA Health's Melanie Rutkowski, PhD, and her team are expanding our understanding of the microbiome and how it influences diseases such as breast and ovarian cancer.
University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer by discovering how gut ...
Results from the PEACOCC trial warrant further investigation into treatment with pembrolizumab in patients with previously ...
Nuvectis is also advancing NXP900 for YES1/SRC-expressing solid tumors, with promising early data showing no dose-limiting ...
The Pardes actress shocked fans in 2022 when Anupam Kher revealed her breast cancer diagnosis. After undergoing chemotherapy and multiple treatments, Mahima successfully defeated cancer. She has since ...
While genetic testing rates for advanced ovarian cancer have increased, gaps in physician understanding and confidence in interpreting results may limit optimal biomarker-driven treatment and patient ...
However, researchers at the Penn Ovarian Cancer Research Center at the University of Pennsylvania are studying a surprising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results